A concise synthesis of valerena-4,7(11)-diene with potent sedative activity was achieved in three steps involving, reduction of carboxylic acid, bromination of the resulting alcohol, and reduction of the bromide from valerenic acid in a 63% total yield. This synthetic method makes it possible to provide further materials for biological testing to realize comprehensive SAR studies.
Valerena-4,7(11)-diene ((2S,5R,6R)-5,9-dimethyl-2-(2-methyl-1-propenyl)bicyclo [4.3 .0]non-1(9)-ene, 1) as shown in Fig. 1 , has been isolated in a small quantity from the roots of Nardostachys chinensis 1, 2) and Valeriana officinalis L., 3, 4) and is a bicyclic sesquiterpene that has recently been shown to dose-dependently reduce the locomotor activity of mice with a particularly profound effect, the strongest sedative activity being observed at a dose of 0.06%. 1) The unique aspect for the pharmacological activity of this compound is that it can be administered via inhalation; the compound is naturally volatile at room temperature and bears a pleasant smell.
1) It may hopefully be developed as a less-harmful remedy for attention deficit hyperactivity disorder (ADHD) and for the confused elderly. An efficient total synthesis of 1 therefore appears to be of importance, as more extensive and elaborate structural variations are envisaged. Structure-activity relationship (SAR) studies of this natural product would not only be able to elucidate the intrinsic mechanism of action, but would also open a new avenue for exploring the possible mode of action of this compound. However, an efficient method for synthesizing 1 is required before comprehensive SAR studies can become a reality.
Valerenic acid 2, which has been isolated as the main component of Valeriana officinalis and previously synthesized by Mulzer et al. 5) and Altmann et al., 6) was purchased from EXTRASYNTHÈ SE (France) as an optically active compound (½ D À115 (c 0.13, CHCl 3 ). 2 has tranquilizing and/or sedative activity from animal experiments, 7) and the activation of adenosine receptors has been implicated in the action of valerian ingredients. 8) We present here the first concise synthesis of valerena-4,7(11)-diene 1 from valerenic acid 2 as the starting material via the reduction of ,-unsaturated carboxylic acid to allylic alcohol with LiAlH 4 , bromination of the resulting primary alcohol with CBr 4 /PPh 3 , and reduction of the bromide with super hydride.
Scheme 1 shows how the concise synthesis of target compound 1 was achieved in three steps from valerenic acid 2.
Treatment of valerenic acid 2 with LiAlH 4 (LAH) at 0 C for 3 h gave valerenol 3 in a 93% yield without reduction of the conjugated olefin. 9) Alcohol 3 was reacted with triphenylphosphine and then exposed to tetrabromomethane at À10 C for 45 min to afford 4 in an 83% yield. Bromide 4 was converted to desired compound 1 as soon as possible since 4 easily decomposed. Bromide 4 was reacted with LiBHEt 3 at À20 C for 1 h to afford target compound 1 in an 82% yield. Compound 1 showed a minus sign for its specific rotation which is consistent with the natural product.
3)
The 1 H-NMR spectrum of synthetic compound 1 was also completely consistent with the natural product. 3) Characteristic peaks of one olefin and two allylic protons at the C2 and C6 positions were clearly observed. The first concise synthesis of 1 was therefore achieved in three steps from valerenic acid in a 63% total yield to provide further material for biological testing. The synthetic route should be applicable to a variety of derivatives that would be suitable for SAR investigation. Various derivatives of valerena-4,7(11)-diene 1 for SAR could be synthesized by introducing nucleophilic agents including oxygen, nitrogen, and a sulfur group, and by extending the carbon chain on the allylic position by using reactive allyl bromide intermediate 4, in addition to converting to carboxylic acid derivatives by using valerenic acid. We believe that the development of novel active sedatives might quickly become possible from the results of this study. 
Column chromatography was performed on silica gel (70-230 mesh), and TLC was performed on Merck 60 F 254 silica gel plates. NMR spectra were recorded by a Bruker instrument at 400 MHz for protons, and at 100 MHz for 13 C in CDCl 3 , with tetramethylsilane (TMS) used as the internal standard. Chemical shifts () are reported in parts per million (ppm) from TMS. Mass spectra were recorded at 70 eV, and high-resolution mass spectra (HRMS) were obtained by direct injection. Optical rotations were measured by a Jasco DIP-140 polarimeter. All chemicals were of commercially available reagent grade and were without further purification.
(2S,5R,6R)-5,9-Dimethyl-2-(3-hydroxy-2-methyl-1-propenyl)bicyclo[4.3.0]non-1(9)-ene (Valerenol) (3). Valerenic acid 2 (36 mg, 0.15 mmol) in absolute THF (2 ml) was added dropwise to a suspension of LiAlH 4 (41 mg, 1.1 mmol) in absolute THF (2 ml) at 0 C in an N 2 atmosphere, and the mixture was stirred for 3 h in an ice-salt bath. Cold water (10 ml) was added, and the mixture was extracted with AcOEt (3 Â 30 ml). The combined organic solution was washed with brine (3 Â 30 ml), dried over Na 2 SO 4 , and concentrated on a rotary evaporator. The resulting residue was subjected to silica gel column chromatography using AcOEt and hexane (1:8) (2S,5R,6R)-5,9-Dimethyl-2-(3-bromo-2-methyl-1-propenyl)bicyclo[4.3.0]non-1(9)-ene (4). Triphenylphosphine (52.3 mg, 0.2 mmol) was added to a solution of valerenol 3 (31.4 mg, 0.14 mmol) in absolute CH 2 Cl 2 (0.7 ml) at À10 C in an N 2 atmosphere, and the mixture was stirred for 3 min in an ice-salt bath. Carbon tetrabromide (56.7 mg, 0.17 mmol) was added to the mixture at the same temperature, and stirring was continued for 45 min. CH 2 Cl 2 was removed by a rotary evaporator, pentane (2 ml) was added to the residue, and the mixture was stirred at room temperature for 5 min. The mixture was finally subjected to silica gel column chromatography using pentane as the eluent, to afford (2S,5R,6R)-5,9-dimethyl-2-(3-bromo-2-methyl-1-propenyl)bicyclo C in an N 2 atmosphere, and the mixture was stirred for 1 h in an ice-salt bath. Water (5 ml) was added to the solution at À20 C and the mixture was extracted with hexane (3 Â 10 ml). The combined organic solution was washed with brine (3 Â 20 ml), dried over Na 2 SO 4 , and concentrated on a rotary evaporator. The resulting residue was subjected to silica gel column chromatography, using hexane as the eluent, to afford valerena-4,7(11)-diene 1 as a colorless oil in an 82% (10.4 mg) yield. ½ 
